| REVIEW ARTICLE |
|
| Year : 2017 | Volume
: 12
| Issue : 6 | Page : 142-148 |
|
|
The pathogenesis of scleroderma
Latika Gupta1, Sakir Ahmed2, Abhishek Zanwar2
1 Division of Rheumatology, Perelman School of Medicine, University of Philadelphia, Philadelphia, Pennsylvania, USA
2 Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
Correspondence Address:
Latika Gupta
Division of Rheumatology, Perelman School of Medicine, University of Philadelphia, Philadelphia, Pennsylvania
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0973-3698.219083
|
|
|
Systemic sclerosis (SSc) results from the complex interplay between the immune system, vasculature and tissue-repair mechanisms. Endothelial injury is the prime event; environmental triggers in the susceptible individual trigger the pathologic process, which translates into fibrosis. The outcome of SSc is not as bleak as it looked a couple of decades ago. With a greater understanding of older pathways, as well as elucidation of newer ones, the potential targets to block and even reverse fibrosis bring around a revolution in the way we look at this once dreaded disease.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
